Kintara Net Tangible Assets from 2010 to 2024
| KTRA Stock | USD 0.15 0.01 6.25% |
Net Tangible Assets | First Reported 2010-12-31 | Previous Quarter -8.9 M | Current Value -8.5 M | Quarterly Volatility 3.2 M |
Check Kintara Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kintara main balance sheet or income statement drivers, such as Interest Expense of 12 K, Selling General Administrative of 4.7 M or Other Operating Expenses of 12.7 M, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 7.0E-4 or Days Sales Outstanding of 0.0. Kintara financial statements analysis is a perfect complement when working with Kintara Therapeutics Valuation or Volatility modules.
Kintara | Net Tangible Assets |
Latest Kintara Therapeutics' Net Tangible Assets Growth Pattern
Below is the plot of the Net Tangible Assets of Kintara Therapeutics over the last few years. It is the total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. Kintara Therapeutics' Net Tangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kintara Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Net Tangible Assets | 10 Years Trend |
|
Net Tangible Assets |
| Timeline |
Kintara Net Tangible Assets Regression Statistics
| Arithmetic Mean | (3,426,178) | |
| Geometric Mean | 2,171,027 | |
| Coefficient Of Variation | (93.07) | |
| Mean Deviation | 2,543,267 | |
| Median | (1,750,024) | |
| Standard Deviation | 3,188,842 | |
| Sample Variance | 10.2T | |
| Range | 10M | |
| R-Value | (0.72) | |
| Mean Square Error | 5.3T | |
| R-Squared | 0.52 | |
| Significance | 0 | |
| Slope | (512,486) | |
| Total Sum of Squares | 142.4T |
Kintara Net Tangible Assets History
About Kintara Therapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Kintara Therapeutics income statement, its balance sheet, and the statement of cash flows. Kintara Therapeutics investors use historical funamental indicators, such as Kintara Therapeutics's Net Tangible Assets, to determine how well the company is positioned to perform in the future. Although Kintara Therapeutics investors may use each financial statement separately, they are all related. The changes in Kintara Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Kintara Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Kintara Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Kintara Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Tangible Assets | -8.9 M | -8.5 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Kintara Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Kintara Therapeutics' short interest history, or implied volatility extrapolated from Kintara Therapeutics options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Kintara Therapeutics Correlation against competitors. For information on how to trade Kintara Stock refer to our How to Trade Kintara Stock guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for Kintara Stock analysis
When running Kintara Therapeutics' price analysis, check to measure Kintara Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kintara Therapeutics is operating at the current time. Most of Kintara Therapeutics' value examination focuses on studying past and present price action to predict the probability of Kintara Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kintara Therapeutics' price. Additionally, you may evaluate how the addition of Kintara Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
Is Kintara Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kintara Therapeutics. If investors know Kintara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kintara Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.22) | Return On Assets (1.13) | Return On Equity (3.29) |
The market value of Kintara Therapeutics is measured differently than its book value, which is the value of Kintara that is recorded on the company's balance sheet. Investors also form their own opinion of Kintara Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Kintara Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kintara Therapeutics' market value can be influenced by many factors that don't directly affect Kintara Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kintara Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kintara Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kintara Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.